Voltar
Carta Acesso aberto Revisado por pares
BIBTEX RIS

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

2016; Springer Nature; Volume: 52; Issue: 1 Linguagem: Inglês

10.1038/bmt.2016.233

ISSN

1476-5365

Autores

Francesco Saraceni, Benedetto Bruno, Roberto M. Lemoli, Giovanna Meloni, William Arcese, Michele Falda, Fabio Ciceri, Emilio Paolo Alessandrino, Giorgina Specchia, Rosanna Scimè, Roberto Raimondi, Andrea Bacigalupo, Alberto Bosi, Francesco Onida, Alessandro Rambaldi, Francesca Bonifazi, Attilio Olivieri,

Tópico(s)

CAR-T cell therapy research

Resumo

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

Referência(s)